11 Laird P W. Principles and challenges of genome-wide DNA methylation analysis. Nat Rev Genetics, 2010, 11: 191-203
[2]
12 Bock C. Analysing and interpreting DNA methylation data. Nat Rev Genet, 2012, 13: 705-719
[3]
30 Keshet I, Schlesinger Y, Farkash S, et al. Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat Genet, 2006, 38: 149-153
[4]
31 Rauch T A, Zhong X Y, Wu X W, et al. High-resolution mapping of DNA hypermethylation and hypomethylation in lung cancer. Proc Natl Acad Sci USA, 2008, 105: 252-257
[5]
32 Bibikova M, Lin Z W, Zhou L X, et al. High-throughput DNA methylation profiling using universal bead arrays. Genome Res, 2006, 16: 383-393
[6]
33 Bibikova M, Lin Z, Zhou L, et al. High-throughput DNA methylation profiling using universal bead arrays. Genome Res, 2006, 16: 383-393
[7]
34 Brunner A L, Johnson D S, Kim S W, et al. Distinct DNA methylation patterns characterize differentiated human embryonic stem cells and developing human fetal liver. Genome Res, 2009, 19: 1044-1056
[8]
35 Oda M, Glass J L, Thompson R F, et al. High-resolution genome-wide cytosine methylation profiling with simultaneous copy number analysis and optimization for limited cell numbers. Nucleic Acids Res, 2009, 37: 3829-3839
[9]
36 Berman B P, Weisenberger D J, Laird P W. Locking in on the human methylome. Nat Biotechnol, 2009, 27: 341-342
[10]
37 Rauch T, Wang Z D, Zhang X M, et al. Homeobox gene methylation in lung cancer studied by genome-wide analysis with a microarray-based methylated CpG island recovery assay. Proc Natl Acad Sci USA, 2007, 104: 5527-5532
[11]
38 Meissner A, Gnirke A, Bell G W, et al. Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis. Nucleic Acids Res, 2005, 33: 5868-5877
[12]
39 Hodges E, Smith A D, Kendall J, et al. High definition profiling of mammalian DNA methylation by array capture and single molecule bisulfite sequencing. Genome Res, 2009, 19: 1593-1605
[13]
40 Lister R, Pelizzola M, Dowen R H, et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature, 2009, 462: 315-322
[14]
41 Lokk K, Modhukur V, Rajashekar B, et al. DNA methylome profiling of human tissues identifies global and tissue-specific methylation patterns. Genome Biol, 2014, 15: r54
[15]
42 Fortin J P, Labbe A, Lemire M, et al. Functional normalization of 450K methylation array data improves replication in large cancer studies. Genome Biol, 2014, 15: 503
[16]
43 Dedeurwaerder S, Defrance M, Bizet M, et al. A comprehensive overview of Infinium HumanMethylation450 data processing. Brief Bioinform, 2014, 15: 929-941
[17]
44 Wang D, Yan L, Hu Q, et al. IMA: an R package for high-throughput analysis of Illumina''s 450K Infinium methylation data. Bioinformatics, 2012, 28: 729-730
[18]
45 Du P, Kibbe W A, Lin S M. lumi: a pipeline for processing Illumina microarray. Bioinformatics, 2008, 24: 1547-1548
[19]
46 Kilaru V, Barfield R T, Schroeder J W, et al. MethLAB: a graphical user interface package for the analysis of array-based DNA methylation data. Epigenetics, 2012, 7: 225-229
[20]
47 Maksimovic J, Gordon L, Oshlack A. SWAN: subset-quantile within array normalization for Illumina Infinium HumanMethylation450 BeadChips. Genome Biol, 2012, 13: R44
[21]
48 Morris T J, Butcher L M, Feber A, et al. ChAMP: 450K chip analysis methylation pipeline. Bioinformatics, 2014, 30: 428-430
[22]
49 Pidsley R, Wong C C Y, Volta M, et al. A data-driven approach to preprocessing Illumina 450K methylation array data. BMC Genomics, 2013, 14: 293
[23]
50 Triche T J, Weisenberger D J, Van Den Berg D, et al. Low-level processing of Illumina Infinium DNA Methylation BeadArrays. Nucleic Acids Res, 2013, 41: e90
[24]
51 Ball M P, Li J B, Gao Y, et al. Targeted and genome-scale strategies reveal gene-body methylation signatures in human cells. Nat Biotechnol, 2009, 27: 361-368
[25]
52 Meissner A, Mikkelsen T S, Gu H C, et al. Genome-scale DNA methylation maps of pluripotent and differentiated cells. Nature, 2008, 454: 766-770
[26]
53 Frith M C, Mori R, Asai K. A mostly traditional approach improves alignment of bisulfite-converted DNA. Nucleic Acids Res, 2012, 40: e100
[27]
54 Chen P Y, Cokus S J, Pellegrini M. BS Seeker: precise mapping for bisulfite sequencing. BMC Bioinformatics, 2010, 11: 203
[28]
55 Guo W L, Fiziev P, Yan W H, et al. BS-Seeker2: a versatile aligning pipeline for bisulfite sequencing data. BMC Genomics, 2013, 14: 774
[29]
56 Krueger F, Andrews S R. Bismark: a flexible aligner and methylation caller for Bisulfite-Seq applications. Bioinformatics, 2011, 27: 1571-1572
[30]
57 Harris E Y, Ponts N, Le Roch K G, Lonardi S. BRAT-BW: efficient and accurate mapping of bisulfite-treated reads. Bioinformatics, 2012, 28: 1795-1796
[31]
58 Pedersen B, Hsieh T F, Ibarra C, et al. MethylCoder: software pipeline for bisulfite-treated sequences. Bioinformatics, 2011, 27: 2435-2436
[32]
59 Bhasin M, Zhang H, Reinherz E L, et al. Prediction of methylated CpGs in DNA sequences using a support vector machine. FEBS Lett, 2005, 579: 4302-4308
[33]
60 Stevens M, Cheng J B, Li D, et al. Estimating absolute methylation levels at single-CpG resolution from methylation enrichment and restriction enzyme sequencing methods. Genome Res, 2014, 23: 1541-1553
[34]
61 Feltus F A , Lee E K, Costello J F, et al. Predicting aberrant CpG island methylation. Proc Natl Acad Sci USA, 2003, 100: 12253-12258
[35]
62 Fang F, Fan S C, Zhang X G, et al. Predicting methylation status of CpG islands in the human brain. Bioinformatics, 2006, 22: 2204-2209
[36]
63 Cokus S J, Feng S, Zhang X, et al. Shotgun bisulphite sequencing of the Arabidopsis genome reveals DNA methylation patterning. Nature, 2008, 452: 215-219
[37]
64 Bock C, Halachev K, Buch J, et al. EpiGRAPH: user-friendly software for statistical analysis and prediction of (epi)genomic data. Genome Biol, 2009, 10: R14
[38]
65 Fan S C, Zhang M Q, Zhang X G. Histone methylation marks play important roles in predicting the methylation status of CpG islands. Biochem Biophys Res Commun, 2008, 374: 559-564
67 Fan S, Fang F, Zhang X, et al. Putative zinc finger protein binding sites are over-represented in the boundaries of methylation-resistant CpG islands in the human genome. PLoS One, 2007, 2: e1184
[41]
68 Baylin S B, Herman J G, Graff J R, et al. Alterations in DNA methylation: a fundamental aspect of neoplasia. Adv Cancer Res, 1998, 72: 141-196
[42]
69 Yang Y, Nephew K, Kim S. A novel k-mer mixture logistic regression for methylation susceptibility modeling of CpG dinucleotides in human gene promoters. BMC Bioinformatics, 2012, 13: S15
[43]
70 Das R, Dimitrova N, Xuan Z Y, et al. Computational prediction of methylation status in human genomic sequences. Proc Natl Acad Sci USA, 2006, 103: 10713-10716
[44]
1 Wyatt G R. Occurrence of 5-methylcytosine in nucleic acids. Nature, 1950, 166: 237-238
[45]
2 Reik W, Santos F, Dean W. Mammalian epigenomics: reprogramming the genome for development and therapy. Theriogenology, 2003, 59: 21-32
[46]
3 Barlow D P. Genomic imprinting: a mammalian epigenetic discovery model. Annu Rev Genet, 2011, 45, 45: 379-403
[47]
4 Meissner A. Epigenetic modifications in pluripotent and differentiated cells. Nat Biotechnol, 2010, 28: 1079-1088
[48]
5 Jones P A, Baylin S B. The fundamental role of epigenetic events in cancer. Nat Rev Genet, 2002, 3: 415-428
[49]
6 Feinberg A P. Phenotypic plasticity and the epigenetics of human disease. Nature, 2007, 447: 433-440
[50]
7 Eckhardt F, Lewin J, Cortese R, et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet, 2006, 38: 1378-1385
[51]
8 Ziller M J, Gu H C, Muller F, et al. Charting a dynamic DNA methylation landscape of the human genome. Nature, 2013, 500: 477-481
[52]
9 Fan S C, Zhang X G. Progress of bioinformatics study in DNA methylation. Prog Biochem Biophys, 2009, 36: 143-150
[53]
10 Fouse S D, Nagarajan R P, Costello J F. Genome-scale DNA methylation analysis. Epigenomics, 2010, 2: 105-117
[54]
13 Ma X T, Wang Y W, Zhang M Q, et al. DNA methylation data analysis and its application to cancer research. Epigenomics, 2013, 5: 301-316
[55]
14 Wilhelm-Benartzi C S, Koestler D C, Karagas M R, et al. Review of processing and analysis methods for DNA methylation array data. Brit J Cancer, 2013, 109: 1394-1402
[56]
15 Bird A P. CpG islands as gene markers in the vertebrate nucleus. Trends Genet, 1987, 3: 342-347
[57]
16 Tykocinski M L, Max E E. CG dinucleotide clusters in MHC genes and in 5'' demethylated genes. Nucleic Acids Res, 1984, 12: 4385-4396
[58]
17 Gardiner-Garden M, Frommer M. CpG islands in vertebrate genomes. J Mol Biol, 1987, 196: 261-282
[59]
18 Takai D, Jones P A. Comprehensive analysis of CpG islands in human chromosomes 21 and 22. Proc Natl Acad Sci USA, 2002, 99: 3740-3745
[60]
19 Ponger L, Mouchiroud D. CpGProD: identifying CpG islands associated with transcription start sites in large genomic mammalian sequences. Bioinformatics, 2002, 18: 631-633
[61]
20 Hackenberg M, Previti C, Luque-Escamilla P L, et al. CpGcluster: a distance-based algorithm for CpG-island detection. BMC Bioinformatics, 2006, 7: 446
[62]
21 Bock C, Walter J, Paulsen M, et al. CpG island mapping by epigenome prediction. PLoS Comput Biol, 2007, 3: e110
[63]
22 Su J Z, Zhang Y, Lv J, et al. CpG_MI: a novel approach for identifying functional CpG islands in mammalian genomes. Nucleic Acids Research, 2010, 38: e6
[64]
23 Chuang L Y, Yang C H, Lin M C, et al. CpGPAP: CpG island predictor analysis platform. BMC Genetics, 2012, 13: 13
[65]
24 Wu H, Caffo B, Jaffee H A, et al. Redefining CpG islands using hidden Markov models. Biostatistics, 2010, 11: 499-514
[66]
25 Hatada I, Hayashizaki Y, Hirotsune S, et al. A genomic scanning method for higher organisms using restriction sites as landmarks. Proc Natl Acad Sci USA, 1991, 88: 9523-9527
[67]
26 Ohgane J, Aikawa J I, Ogura A, et al. Analysis of CpG islands of trophoblast giant cells by restriction landmark genomic scanning. Dev Genet, 1998, 22: 132-140
[68]
27 Toyota M, Ho C, Ahuja N, et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res, 1999, 59: 2307-2312
[69]
28 Khulan B, Thompson R F, Ye K, et al. Comparative isoschizomer profiling of cytosine methylation: the HELP assay. Genome Res, 2006, 16: 1046-1055
[70]
29 Weber M, Hellmann I, Stadler M B, et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet, 2007, 39: 457-466
[71]
71 Zheng X Q, Zhao Q, Wu H J, et al. MethylPurify: tumor purity deconvolution and differential methylation detection from single tumor DNA methylomes. Genome Biol, 2014, 15: 419
[72]
72 Bird A. DNA methylation patterns and epigenetic memory. Genes Dev, 2002, 16: 6-21
[73]
73 VanderKraats N D, Hiken J F, Decker K F, et al. Discovering high-resolution patterns of differential DNA methylation that correlate with gene expression changes. Nucleic Acids Res, 2013, 41: 6816-6827
[74]
74 Su J Z, Yan H D, Wei Y J, et al. CpG_MPs: identification of CpG methylation patterns of genomic regions from high-throughput bisulfite sequencing data. Nucleic Acids Res, 2013, 41: e41
[75]
75 Byun H M, Siegmund K D, Pan F, et al. Epigenetic profiling of somatic tissues from human autopsy specimens identifies tissue- and individual-specific DNA methylation patterns. Hum Mol Genet, 2009, 18: 4808-4817
[76]
76 Nagae G, Isagawa T, Shiraki N, et al. Tissue-specific demethylation in CpG-poor promoters during cellular differentiation. Hum Mol Genet, 2011, 20: 2710-2721
[77]
77 Fernandez A F, Assenov Y, Martin-Subero J I, et al. A DNA methylation fingerprint of 1628 human samples. Genome Res, 2012, 22: 407-419
[78]
78 Illingworth R S, Bird A P. CpG islands—‘A rough guide’. FEBS Lett, 2009, 583: 1713-1720
[79]
79 Zhang Y, Liu H B, Lv J, et al. QDMR: a quantitative method for identification of differentially methylated regions by entropy. Nucleic Acids Res, 2011, 39: e58
[80]
80 Li D, Zhang B, Xing X, et al. Combining MeDIP-seq and MRE-seq to investigate genome-wide CpG methylation. Methods, 2015, 72: 29-40
[81]
81 Jones P A, Baylin S B. The epigenomics of cancer. Cell, 2007, 128: 683-692
[82]
82 Esteller M. Molecular origins of cancer: epigenetics in cancer. New Engl J Med, 2008, 358: 1148-1159
[83]
83 Turcan S, Rohle D, Goenka A, et al. IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature, 2012, 483: 479-483
[84]
84 Desplats P, Spencer B, Coffee E, et al. a-synuclein sequesters Dnmt1 from the nucleus: a novel mechanism for epigenetic alterations in Lewy body diseases. J Biol Chem, 2011, 286: 9031-9037
[85]
85 Javierre B M, Fernandez A F, Richter J, et al. Changes in the pattern of DNA methylation associate with twin discordance in systemic lupus erythematosus. Genome Res, 2010, 20: 170-179
[86]
86 Nakano K, Whitaker J W, Boyle D L, et al. DNA methylome signature in rheumatoid arthritis. Ann Rheum Dis, 2013, 72: 110-117
[87]
87 Assenov Y, Muller F, Lutsik P, et al. Comprehensive analysis of DNA methylation data with RnBeads. Nat Methods, 2014, 11: 1138-1140
[88]
88 Akalin A, Kormaksson M, Li S, et al. methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles. Genome Biol, 2012, 13: R87
